Home / Products / Genome-edited Cells / HMOX2 Knockout HaCaT Cell Line

HMOX2 Knockout HaCaT Cell Line

Cat. No. ARG0256
Product Type:

Genome-edited Cells

Tissue Source:

Skin

In stock
Request a Quote

Short Description 🔒

The HMOX2 Knockout HaCaT Cell Line is a CRISPR/Cas9-edited human keratinocyte line with targeted HMOX2 disruption, enabling loss-of-function studies in epidermal biology. Derived from spontaneously immortalized HaCaT cells, it provides a relevant model for investigating heme metabolism and oxidative stress responses. This model facilitates research into cytoprotection, ferroptosis, and carbon monoxide signaling, with key downstream effectors including biliverdin, bilirubin, and ferrous iron. Representative assays encompass heme oxygenase activity measurements, ROS detection, and lipid peroxidation analysis, applicable to skin aging and dermatological disease research.

Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Genome-edited Cells
Tissue Source:
Skin
Disease:
Normal
Age:
62 years
Sex of Donor:
Male
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

Host Cell:
HaCaT
Gene Name:
HMOX2
Gene Identifier:
NCBI Gene ID 3163
Gene Species:
Homo sapiens (Human)

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

The HMOX2 Knockout HaCaT Cell Line is a CRISPR/Cas9-edited knockout cell line derived from the immortalized human keratinocyte HaCaT cell line, designed for loss-of-function studies of the HMOX2 gene. This product provides a constitutive disruption of HMOX2, enabling researchers to investigate the role of heme oxygenase-2 in cellular models relevant to epidermal biology and oxidative stress.

HaCaT cells are a spontaneously immortalized, non-tumorigenic human keratinocyte line originated from adult skin. They retain the capacity for normal epidermal differentiation, making them a widely employed model for studying keratinocyte biology, skin diseases, and cutaneous responses to environmental stressors. Their genetic stability and ease of handling facilitate reproducible experimental setups.

HMOX2 encodes heme oxygenase-2, an enzyme that constitutively cleaves heme into equimolar amounts of biliverdin, carbon monoxide (CO), and ferrous iron. Biliverdin is subsequently reduced to bilirubin by biliverdin reductase, providing antioxidant defense. CO functions as a gasotransmitter, modulating cell signaling and apoptosis. The enzyme interacts with calmodulin, NADPH-cytochrome P450 reductase, and biliverdin reductase, and requires NADPH as a cofactor. Its activity is regulated by heme, oxidative stress, and iron-regulatory proteins. Representative pathway components include HMOX1, HMOX2, heme, biliverdin reductase, bilirubin, CO, iron, ferritin, ferroportin, and NADPH, underscoring the role of HMOX2 in iron homeostasis, antioxidant defense, and gasotransmitter signaling.

In keratinocytes, HMOX2-mediated heme degradation is particularly significant given the high exposure of skin to oxidative insults. The release of CO and iron can influence keratinocyte proliferation, differentiation, and survival, while bilirubin acts as a potent antioxidant. Disruption of HMOX2 in HaCaT cells provides a powerful model to dissect the enzyme’s contributions to cytoprotection, ferroptosis resistance, and signaling pathways relevant to skin aging, wound healing, and disorders such as psoriasis.

The HMOX2 Knockout HaCaT Cell Line is suited for applications including quantitative assessment of HMOX2 mRNA and protein levels by RT-qPCR and western blotting, measurement of heme oxygenase activity, gas chromatographic detection of CO production, and quantification of bilirubin and iron. It supports functional analyses under oxidative stress conditions using ROS detection, cell viability assays, and lipid peroxidation assessments for ferroptosis research. This knockout model facilitates mechanistic studies of heme metabolism and CO signaling in keratinocyte biology and skin-related pathologies. For further information, please contact Ascent Research.